We are live on ! Find out more
RXII

GALENA BIOPHARMA INC COM
RXII

Delisted

RXII was delisted on the 25th of October, 2011.

Back to rankings

0 hedge funds and large institutions have $0 invested in GALENA BIOPHARMA INC COM in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 91 → 0 (-91)

100% less capital invested

Capital invested by funds: $11.5M → $0 (-$11.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 90

Holders
–
Holders Change
-91
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
90
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$2.93M
2
BFA
BlackRock Fund Advisors
California
-$2.11M
3
BIT
BlackRock Institutional Trust
California
-$1.54M
4
State Street
State Street
Massachusetts
-$1.01M
5
Northern Trust
Northern Trust
Illinois
-$715K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
– -$2.93M -8,373,637 Closed
BFA
2
BlackRock Fund Advisors
California
– -$2.11M -6,014,689 Closed
BIT
3
BlackRock Institutional Trust
California
– -$1.54M -4,398,909 Closed
State Street
4
State Street
Massachusetts
– -$1.01M -2,882,645 Closed
Northern Trust
5
Northern Trust
Illinois
– -$715K -2,041,633 Closed
Goldman Sachs
6
Goldman Sachs
New York
– -$516K -1,472,527 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$455K -1,301,165 Closed
BIM
8
BlackRock Investment Management
Delaware
– -$248K -708,015 Closed
TCIM
9
TIAA CREF Investment Management
New York
– -$228 -650,350 Closed
Bank of New York Mellon
10
Bank of New York Mellon
New York
– -$212K -601,414 Closed
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
– -$188K -535,907 Closed
California Public Employees Retirement System
12
California Public Employees Retirement System
California
– -$165K -471,657 Closed
California State Teachers Retirement System (CalSTRS)
13
California State Teachers Retirement System (CalSTRS)
California
– -$155K -442,650 Closed
TA
14
Teachers Advisors
New York
– -$99K -281,597 Closed
Charles Schwab
15
Charles Schwab
California
– -$93K -265,000 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$81K -231,428 Closed
RhumbLine Advisers
17
RhumbLine Advisers
Massachusetts
– -$65K -185,945 Closed
Wells Fargo
18
Wells Fargo
California
– -$62K -177,335 Closed
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
– -$52K -147,900 Closed
SM
20
Sabby Management
Florida
– -$49K -141,000 Closed
AllianceBernstein
21
AllianceBernstein
Tennessee
– -$48K -137,500 Closed
Group One Trading
22
Group One Trading
Illinois
– -$47K -135,018 Closed
JMPWA
23
JP Morgan Private Wealth Advisors
California
– -$46K -130,373 Closed
NFA
24
Nationwide Fund Advisors
Ohio
– -$42K -119,722 Closed
Wolverine Trading
25
Wolverine Trading
Illinois
– -$37K -112,187 Closed
1
2 3 4

RXII Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q4 2016, worth a combined $0 — down 100% from $11.5M a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of RXII and 0 opened new positions — a net loss of 90 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $2.93M sold.

  • 0 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q4 2016, down from 91 in Q3 2016.
  • Funds reported $0 of GALENA BIOPHARMA INC COM stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new GALENA BIOPHARMA INC COM positions in Q4 2016 and 90 closed out, a net change of -90 holders.
  • The largest GALENA BIOPHARMA INC COM seller in Q4 2016 was Vanguard Group, an estimated $2.93M sold.

Based on aggregated 13F filings for Q4 2016.